Previous 10 | Next 10 |
home / stock / lxxgf / lxxgf news
Technology Accurately Identifies Pathogens and Predicts Antimicrobial Resistance In less than 30 years, drug resistant bacteria are predicted to kill 3 times more people on an annual basis than COVID-19 did in 2020 MiQLab is a diagnostic tool used for detecting drug resistance...
LexaGene to Webcast Live at VirtualInvestorConferences.com October 7th Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com PR Newswire BEVERLY, Ma...
BEVERLY, Mass., Oct. 01, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a commercial molecular diagnostics company selling a point-of-need highly multiplexed in-clinic PCR system wi...
Live Investor Conference & Webinar: Small Cap Growth Conference on October 7th Live Investor Conference & Webinar: Small Cap Growth Conference on October 7th Company executives will share vision and answer audience questions at VirtualInvestorConferences.com PR N...
BEVERLY, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a commercial molecular diagnostics company selling a point-of-need highly multiplexed in-clinic PCR system w...
BEVERLY, Mass., Sept. 17, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a commercial molecular diagnostics company selling a point-of-need highly multiplexed in-clinic PCR system w...
BEVERLY, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( TSX-V: LXG ; OTCQB: LXXGF ) (the “ Company ”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce it has ente...
MiQLab detected both bacterial strains in polymicrobial samples in ~2 hours Culture and Sensitivity Testing (C&ST) failed to detect the minor pathogen population in individual mixed samples, with final test results taking up to 11 days MiQLab testing can improve treatment de...
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES BEVERLY, Mass., Sept. 03, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: ...
September 7-9, WVC 93 rd Annual Conference, Las Vegas, NV September 12-14, International Veterinary Emergency and Critical Care, Nashville, TN September 23-26, Southwest Veterinary Symposium, San Antonio, TX BEVERLY, Mass., Sept. 03, 2021 (GLOBE...
News, Short Squeeze, Breakout and More Instantly...
BEVERLY, Mass., Feb. 24, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), announces that it has ceased operations, laid off its staff, and, together with its direct subsidiary LexaGene, Inc., and its indir...
BEVERLY, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“ LexaGene ” or the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab™ System for automated mul...
BEVERLY, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab™ System for automate...